Antiviral Inhibition of the HIV-1 capsid protein

Journal of Molecular Biology

Volumn 327, Issue 5, 2003, Pages 1013-1020

  Tang, Chun ^a   Loeliger, Erin ^a   Kinde, Isaac ^a   Kyere, Samson ^a   Mayo, Keith ^b   Barklis, Eric ^b   Sun, Yongnian ^c   Huang, Mingjun ^c   Summers, Michael F ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c Achillion Pharmaceuticals   (United States)

Author keywords

Antiviral inhibitors; Capsid assembly; HIV 1; Nuclear magnetic resonance

Indexed keywords

1 [4 (N METHYLACETAMIDO)PHENYL] 3 (4 METHYL 3 NITROPHENYL)UREA; CAPSID PROTEIN; N (3 CHLORO 4 METHYLPHENYL) N' [2 [[[5 [(DIMETHYLAMINO)METHYL] 2 FURYL]METHYL]SULFANYL]ETHYL]UREA; UNCLASSIFIED DRUG; UREA DERIVATIVE;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CULTURE; CELL LINE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; MATURATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN PROTEIN INTERACTION; REVERSE TRANSCRIPTION; VIROGENESIS; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CORE; VIRUS DNA CELL DNA INTERACTION; VIRUS INFECTIVITY; VIRUS INHIBITION; VIRUS MORPHOLOGY; VIRUS PARTICLE;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 0037432551     PISSN: 00222836     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-2836(03)00289-4     Document Type: Article

References (43)

1. Richman D.D. HIV chemotherapy. Nature. 410:2001;995-1001.
2. Pillay D., Taylor S., Richman D.D. Incidence and impact of resistance against approved antiretroviral drugs. Rev. Med. Virol. 10:2000;231-253.
3. Mansky L.M., Pearl D.K., Gajary L.C. Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies. J. Virol. 76:2002;9253-9259.
4. Coffin J. HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy. Science. 267:1995;483-489.
5. Kuritzkes D.R. Clinical significance of drug resistance in HIV-1 infection. AIDS. 10:1996;S27-S33.
6. Vogt, V. personal communication.
7. Gitti R.K., Lee B.M., Walker J., Summers M.F., Yoo S., Sundquist W.I. Structure of the amino-terminal core domain of the HIV-1 capsid protein. Science. 273:1996;231-235.
8. von Schwedler U.K., Stemmler T.L., Klishko V.Y., LI S., Albertine K.H., Davis D.R., Sundquist W.I. Proteolytic refolding of the HIV-1 capsid protein amino-terminus facilitates viral core assembly. EMBO J. 17:1998;1555-1568.
9. Gross I., Hohenberg H., Juckhagel C., Krausslich H.-G. N-terminal extension of human immunodeficiency virus capsid protein converts the in vitro assembly phenotype from tubular to spherical particles. J. Virol. 72:1998;4798-4810.
10. Tang C., Ndassa Y., Summers M.F. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein. Nat. Struct. Biol. 9:2002;537-543.
11. Tang S., Murakami T., Agresta B.E., Campbell S., Freed E.O., Levin J.G. Human immunodeficiency virus type 1 N-terminal capsid mutants that exhibit aberrant core morphology are blocked in initiation of reverse transcription in infected cells. J. Virol. 75:2001;9357-9366.
12. Reicin A.S., Ohagen A., Yin L., Hoglund S., Goff S.P. The role of Gag in human immunodeficiency virus type 1 virion morphogenesis and early steps of the viral life cycle. J. Virol. 70:1996;8645-8652.
13. Forshey B.M., von Schwedler U., Sundquist W.I., Aiken C. Formation of a human immunodeficiency virus type 1 core of optimal stability is crucial for viral replication. J. Virol. 76:2002;5667-5677.
14. Smith T.J., Kremer M.J., Luo M., Vriend G., Arnold E., Kamer G., Rossmann M.G., McKinlay M.A., Diana G.D., Otto M.J. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science. 233:1986;1286-1293.
15. Deres K., Schroder C.H., Paessens A., Goldmann S., Hacker H.J., Weber O., Kramer T., Niewohner U., Pleiss U., Stoltefuss J., Graef E., Koletzki D., Masantschek R.N.A., Reimann A., Jaeger R., Grob R., Beckermann B., Schlemmer K.-H., Haebich D., Rubsamen-Waigmann H. Inhibition of hepatitis B virus replication by drug-induced depletion of nucleocapsids. Science. 299:2003;893-896.
16. Rossmann M.G. Antiviral agents targeted to interact with viral capsid proteins and a possible application to human immunodeficiency virus. Proc. Natl. Acad. Sci. U.S.A. 85:1988;4625-4627.
17. Gamble T.R., Vajdos F., Yoo S., Worthylake D.K., Houseweart S.M., Sundquist W.I., Hill C.P. Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid. Cell. 87:1996;1285-1294.
18. Gamble T.R., Yoo S., Vajdos F.F., von Schwedler U.K., Korthylake D.K., Wang H., McCutcheon J.P., Sundquist W.I., Hill C.P. Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein. Science. 278:1997;849-853.
19. Ewing T.J.A., Kuntz I.D. Critical evaluation of search algorithms for automated molecular docking and database screening. J. Comp. Chem. 18:1997;1175-1189.
20. Ehrlich L.S., Agresta B.E., Agresta A., Agresta C.C. Assembly of recombinant human immunodeficiency virus type 1 capsid protein in vitro. J. Virol. 66:1992;4874-4883.
21. Gross I., Hohenberg H., Krausslich H.-G. In vitro assembly properties of purified bacterially expressed capsid proteins of human immunodeficiency virus. Eur. J. Biochem. 249:1997;592-600.
22. Gross I., Hohenberg H., Wilk T., Wiegers K., Grattinger M., Muller B., Fuller S., Krausslich H.-G. A conformational switch controlling HIV-1 morphogenesis. EMBO J. 19:2000;103-113.
23. Lanman J., Sexton J., Sakalian M., Prevelige P.E. Jr. Kinetic analysis of the role of intersubunit interactions in human immunodeficiency virus type 1 capsid protein assembly in vitro. J. Virol. 76:2002;6900-6908.
24. Engelman A., Englund G., Orenstein J.M., Martin M.A., Craigie R. Multiple effects of mutations in human immunodeficiency virus type 1 integrase on viral replication. J. Virol. 69:1995;2729-2736.
25. Gelderblom H.R. Assembly and Morphology of HIV: Potential Effect of Structure on Viral Function. AIDS. 5:1991;617-637.
26. Höglund S., Öfverstedt L.-G., Nilsson Å., Lundquist P., Gelderblom H., Özel M., Skoglund U. Spatial Visualization of the Maturing HIV-1 Core and Its Linkage to the Envelope. AIDS Research and Human Retroviruses. 8:1992;1-7.
27. Kong L.B., An D., Ackerson B., Canon J., Rey O., Chen I.S.Y., Krogstad P., Steward P.L. Cryoelectron microscopy examination of human immunodeficiency virus type-1 virions with mutations in the cyclophilin A binding loop. J. Virol. 72:1998;4403-4407.
28. Dorfman A.T., Bukovsky A., Ohagen A.S., Hoglund H., Gottlinger G. Functional domains of the capsid protein of human immunodeficiency virus type 1. J. Virol. 68:1994;8180-8187.
29. Kuiken C.L., Foley B., Hahn B., Marx P.A., McCutchan F., Mellors J., Mullins J.I., Wolinksy S., Korber B. HIV Sequence Compendium 2001. 2001;Theoretical Biology and Biophysics Group, Los Alomos National Laboratory, Los Alomos.
30. Lanman J., Lam T.T., Barnes S., Sakalian M., Emmett M.R., Marshall A.G., Prevelige P.E. Jr. Identification of novel interactions in HIV-1 capsid protein assembly by high-resolution mass spectrometry. J. Mol. Biol. 325:2003;759-772.
31. Lin J.-H., Perryman A.L., Schames J.R., McCammon J.A. Computational drug design accommodating receptor flexibility: The relaxed complex scheme. J. Am. Chem. Soc. 124:2002;5632-5633.
32. Arkin M.R., Randal M., DeLano W.L., Hyde J., Luong T.N., Oslob J.D., Raphael D.R., Taylor L., Wang J., McDowell R.S., Wells J.A., Braisted A.C. Binding of small molecules to an adaptive protein-protein interface. Proc. Natl. Acad. Sci. USA. 100:2003;1603-1608.
33. Rodgers D.W., Gamblin S.J., Harris B.A., Ray S., Culp J.S., Hellmig B., Woolf D.J., Debouck C., Harrison S.C. The structure of unliganded reverse transcriptase from the human immunodeficiency virus type 1. Proc. Natl Acad. Sci. USA. 92:1995;1222-1226.
34. Garrus J.E., von Schwedler U.K., Pornillos O.W., Morham S.G., Zavitz K.H., Wang H.E., Wettstein D.A., Stray K.M., Cote M.L., Rich R.L., Myszka D.G., Sundquist W.I. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell. 107:2001;55-65.
35. Schubert U., Ott D.E., Chertova E.N., Welker R., Tessmer U., Princiotta M.F., et al. Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc. Natl. Acad. Sci. USA. 97:2000;13057-13062.
36. Strack B., Calistri A., Accola M.A., Palu G., Gottlinger H.G. A role for ubiquitin ligase recruitment in retrovirus release. Proc. Natl. Acad. Sci. USA. 97:2000;13063-13068.
37. Patnaik A., Chau V., Wills J.W. Ubiquitin is part of the retrovirus budding machinery. Proc. Natl. Acad. Sci. USA. 97:2000;13069-13074.
38. Adachi A., Gendelman H.E., Koenig S., Folks T., Willey R., Rabson A., Martin M.A. Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J. Virol. 59:1986;284-291.
39. Kay L.E., Ikura M., Tschudin R., Bax A. Three-dimensional triple-resonance NMR spectroscopy of isotopically enriched proteins. Journal of Magnetic Resonance. 89:1990;496-514.
40. Kimpton J., Emerman M. Detection of replication-competent and pseudotyped HIV with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:1992;2232-2239.
41. Huang M., Orenstein J.M., Martin M.A., Freed E.O. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J. Virol. 96:1995;6810-6818.
42. Huang M., Zensen R., Cho M., Martin M.A. Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant. J. Virol. 72:1998;2047-2054.
43. DeLano Scientific. (2002). The PyMOL molecular graphics system. DeLano, W. L.